Two Sigma Investments’s Century Therapeutics IPSC Stock Holding History

Two Sigma Investments’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.36M	Buy	2,371,430 +875,514	+59%	+$1.84M	﹤0.01%	1927
2025 Q4	$1.49M	Buy	1,495,916 +584,470	+64%	+$357K	﹤0.01%	2667
2025 Q3	$454K	Buy	911,446 +338,902	+59%	+$183K	﹤0.01%	3022
2025 Q2	$320K	Buy	572,544 +486,538	+566%	+$261K	﹤0.01%	2766
2025 Q1	$40.9K	Buy	86,006 +19,209	+29%	+$14.4K	﹤0.01%	3064
2024 Q4	$67.5K	Buy	+66,797	New	+$90.9K	﹤0.01%	3015
2023 Q3	–	Sell	-15,864	Closed	-$50.1K	–	3078
2023 Q2	$50.1K	Sell	15,864 -21,354	-57%	-$68.8K	﹤0.01%	2831
2023 Q1	$129K	Buy	37,218 +1,356	+4%	+$5.96K	﹤0.01%	2641
2022 Q4	$184K	Buy	+35,862	New	+$339K	﹤0.01%	2409

Other funds holding IPSC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Two Sigma Investments's IPSC Position: Q1 2026 in Review

Two Sigma Investments increased its Century Therapeutics (IPSC) stake by 59% in Q1 2026, buying an estimated $1.84M and bringing the position to 2,371,430 shares worth $5.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1927.

Two Sigma Investments first reported a position in IPSC in Q4 2022 and has held it in 9 quarters since. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

Two Sigma Investments held 2,371,430 shares of Century Therapeutics worth $5.36M as of Q1 2026.
Two Sigma Investments bought 875,514 Century Therapeutics shares in Q1 2026, an estimated $1.84M.
Century Therapeutics made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1927 holding.
Two Sigma Investments first reported a position in Century Therapeutics in Q4 2022 and has held it in 9 quarters since.
72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.